Skip to main content
OpenTrials
Completed

NCT Number: NCT02810561

Troponin Leaks in Emergency Department Patients Presenting With Supraventricular Tachycardia (SVT)

The goal of this study is twofold. First the investigators would like to determine the trajectory of troponin leaks; if it can be shown that the participants who have only minimal elevations of their repeat troponin universally decrease on the 3rd level then future patients may see significantly improved length of stay. Second, given conflicting results in the literature, the investigators would like to determine if elevated troponin levels correlate to later cardiovascular complications. These complications will be defined as Death, Myocardial Infarction, Cardiovascular intervention (such as coronary artery stenting or bypass). As the investigator is a single hospital system in this county it is uniquely positioned to be able to review this retrospectively.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Supraventricular Tachycardia Arrhythmias, Cardiac Cardiac Conduction System Disease Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Tachycardia Tachycardia, Supraventricular

Sex eligibility

All sexes

Study type

Observational

About this study

The investigators therefore propose retrospectively studying participants diagnosed with Supraventricular Tachycardia who had troponin(s) checked in the ED between January 1, 2012 and May 31, 2016 to allow a minimum of a year follow-up for our combined endpoint. The investigators will record the participants troponin value(s) in addition to the age, sex, race, heart rate, creatinine value. The investigators will compare the participants with positive troponins (and hopefully participants with strongly positive troponins) with those who are negative for troponin for presence of the combined end point via chart review.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Supraventricular Tachycardia with troponin elevation

Exclusion criteria

  • Other cardiac arrhythmias or conditions with increased troponin

Treatment and study plan

No intervention

Other

No intervention was completed with this study.

Primary outcomes

  1. Troponin-I Level

    Time frame: 6 hours after initial EKG

    Measured in ng/ml

Secondary outcomes

  1. Death/ Need for Cardiac Stent Placement or Coronary Bypass Artery Graft

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Corewell Health South

Other

Registry information

Official study title

Time Course and the Significance of Troponin Leaks in Emergency Department Patients Presenting With Supraventricular Tachycardia (SVT)

Important dates

Study start
2012
Primary completion
2016
Study completion
2016
First posted
Jun 23, 2016
Registry last updated
Aug 17, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.